Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. Australia
  4. Australian Stock Exchange
  5. Antisense Therapeutics Limited
  6. Notizie
  7. Altre lingue
    ANP   AU000000ANP4

ANTISENSE THERAPEUTICS LIMITED

(ANP)
RiassuntoGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioni 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su ANTISENSE THERAPEUTICS LIMITED
04/10ANTISENSE THERAPEUTICS LIMITED: Antisense Therapeutics ernennt neuen Non-Executive Direct..
04/10ANTISENSE THERAPEUTICS LIMITED: -2-
04/10ANTISENSE THERAPEUTICS LIMITED: Antisense Therapeutics ernennt neuen Non-Executive Direct..
04/10Antisense Therapeutics Appoints Gil Price as New Non-Executive Director
30/09ANTISENSE THERAPEUTICS LIMITED: Antisense Therapeutics: Positive Rückmeldung zum pädiatri..
30/09ANTISENSE THERAPEUTICS LIMITED: -2-
30/09ANTISENSE THERAPEUTICS LIMITED: Antisense Therapeutics: Positive Rückmeldung zum pädiatri..
27/09ANTISENSE THERAPEUTICS LIMITED: Antisense Therapeutics Limited: Statistisch signifikante ..
27/09ANTISENSE THERAPEUTICS LIMITED: Antisense Therapeutics Limited: Statistisch signifikante ..
27/09ANTISENSE THERAPEUTICS LIMITED: -2-
24/09ANTISENSE THERAPEUTICS': ATL1102 Drug Shows Clinical Potential in Phase 2 Study; Shares J..
24/09Antisense Therapeutics Limited Announces New Data Supports ATL1102s Broader Clinical Po..
21/09DGWA - FINEST FINANCIAL ENGINEERING: DGWA: Antisense Therapeutics veröffentlicht Investor..
20/09ANTISENSE THERAPEUTICS LIMITED: Antisense Therapeutics Limited: Neue proteomische Daten z..
20/09ANTISENSE THERAPEUTICS LIMITED: Antisense Therapeutics Limited: Neue proteomische Daten z..
07/09ANTISENSE THERAPEUTICS LIMITED: Antisense: Welt-Duchenne-Tag - 7. September
07/09ANTISENSE THERAPEUTICS LIMITED: Antisense: Welt-Duchenne-Tag - 7. September
02/09PRESS RELEASE: Secarna Pharmaceuticals GmbH & Co. KG: Secarna Pharmaceuticals and Evotec ..
25/08Antisense Therapeutics Limited Auditor Raises 'Going Concern' Doubt
24/08IRW-NEWS: Antisense Therapeutics Limited: Antisense beteiligt sich an der von PPMD initii..
24/08IRW-PRESS: Antisense Therapeutics Limited: -2-
24/08IRW-PRESS: Antisense Therapeutics Limited: Antisense beteiligt sich an der von PPMD initi..
12/08IRW-NEWS: Antisense Therapeutics Limited: Antisense Therapeutics: ANP informiert über die..
12/08IRW-PRESS: Antisense Therapeutics Limited: -2-
12/08IRW-PRESS: Antisense Therapeutics Limited: Antisense Therapeutics: ANP informiert über di..
12/08ANP Updates on US Regulatory Plans for ATL1102 in DMD
28/07IRW-NEWS: Antisense Therapeutics Limited: Antisense Therapeutics ernennt neue Vorstandsvo..
28/07IRW-PRESS: Antisense Therapeutics Limited: Antisense Therapeutics ernennt neue Vorstandsv..
28/07ANTISENSE THERAPEUTICS: Appoints Non-Executive Director as New Chair; Shares Rise 5%
28/07Antisense Therapeutics Limited Announces Executive Changes
02/07ANTISENSE THERAPEUTICS: Morgans rates ANP as Add
28/06IRW-PRESS: Antisense Therapeutics Limited: -2-
28/06IRW-NEWS: Antisense Therapeutics Limited: Antisense Therapeutics und das Murdoch Children..
28/06IRW-PRESS: Antisense Therapeutics Limited: Antisense Therapeutics und das Murdoch Childre..
28/06Antisense Therapeutics and Murdoch Children's Research Institute Enter into New R&D Col..
22/06IRW-NEWS: Antisense Therapeutics Limited: Antisense: Rückmeldung der EMA zum PIP für die ..
22/06IRW-PRESS: Antisense Therapeutics Limited: Antisense: Rückmeldung der EMA zum PIP für die..
22/06IRW-PRESS: Antisense Therapeutics Limited: -2-
01/06IRW-NEWS: Antisense Therapeutics Limited: Antisense Therapeutics: Rückmeldung der US-amer..
01/06IRW-PRESS: Antisense Therapeutics Limited: -2-
01/06IRW-PRESS: Antisense Therapeutics Limited: Antisense Therapeutics: Rückmeldung der US-ame..
01/06Antisense Therapeutics Limited Announces US FDA Feedback on Type C Meeting for ATL1102 ..
26/05IRW-NEWS: Antisense Therapeutics Limited: Antisense Therapeutics: Herstellung von klinisc..
26/05IRW-PRESS: Antisense Therapeutics Limited: -2-
26/05IRW-PRESS: Antisense Therapeutics Limited: Antisense Therapeutics: Herstellung von klinis..
26/05ANTISENSE THERAPEUTICS: Completes Manufacturing of Clinical Supplies for Phase 2b Trial o..
26/05Antisense Therapeutics Limited Announces Manufacture of ATL1102 clinical supplies for P..
23/04ANTISENSE THERAPEUTICS: Completes Type C Meeting with US FDA on Drug Candidate
21/03Antisense Therapeutics Limited Announces Board Changes
25/02IRW-NEWS: Antisense Therapeutics Limited: Pädiatrisches Prüfkonzept für ATL1102 bei DMD b..
25/02IRW-PRESS: Antisense Therapeutics Limited: -2-
25/02IRW-PRESS: Antisense Therapeutics Limited: Pädiatrisches Prüfkonzept für ATL1102 bei DMD ..
24/02Antisense Therapeutics Limited Announces the Paediatric Investigation Plan for ATL1102 ..
24/02Antisense Therapeutics Limited Announces Executive Changes
14/01Antisense Therapeutics Limited Announces Change of Registered Office and Principal Plac..
2020IRW-NEWS: Antisense Therapeutics Limited: Antisense Therapeutics Limited: Europäische Kom..
2020IRW-PRESS: Antisense Therapeutics Limited: -2-
2020IRW-PRESS: Antisense Therapeutics Limited: Antisense Therapeutics Limited: Europäische Ko..
2020ANTISENSE THERAPEUTICS: Gets Orphan Drug Designation for Duchenne Muscular Dystrophy; Sha..
2020IRW-NEWS: Antisense Therapeutics Limited: Antisense Therapeutics Limited (ASX: ANP, WKN: ..
2020IRW-PRESS: Antisense Therapeutics Limited: Antisense Therapeutics Limited (ASX: ANP, WKN:..
2020ANTISENSE THERAPEUTICS': Share Purchase Plan Oversubscribed; Shares Rise 6%
2020IRW-NEWS: Antisense Therapeutics Limited: Korrekturmeldung: Antisense Therapeutics inform..
2020IRW-PRESS: Antisense Therapeutics Limited: Korrekturmeldung: Antisense Therapeutics infor..
2020IRW-NEWS: Antisense Therapeutics Limited: Antisense Therapeutics informiert über Zweitlis..
2020IRW-PRESS: Antisense Therapeutics Limited: Antisense Therapeutics informiert über Zweitli..
2020ANTISENSE THERAPEUTICS: Commences Trading on Frankfurt Stock Exchange; Shares Up 5%
2020ANTISENSE THERAPEUTICS: Gets Positive Opinion for Duchenne Muscular Atrophy Treatment; Ra..
2020Antisense Therapeutics Limited Receives Positive Opinion from EMA on Orphan Drug Design..
2020ANTISENSE THERAPEUTICS: Rises 15% After Announcing Plans for Second Listing on Frankfurt ..
2020ANP Receives US FDA ODD for ATL1102 in DMD
2020Antisense Therapeutics Limited Announces Statistically Significant Improvement in Pul2...
2020Antisense Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30..
2020Antisense Therapeutics Limited Auditor Raises 'Going Concern' Doubt
2020Antisense Therapeutics Limited Submits US Orphan Drug Application for ATL1102 in DMD
1  2  3Pross.
Prossimo evento su ANTISENSE THERAPEUTICS LIMITED
23/02/22